Evangelia Ttofi

Evangelia Ttofi has worked in the field of intellectual property since 2008. Evangelia began their career as a European Patent Attorney at Potter Clarkson LLP and held this role until 2013. Evangelia then moved to AstraZeneca, where they worked as a European Patent Attorney until 2021. Currently, they are the Head of IP at Purespring Therapeutics.

Evangelia Ttofi earned their PhD in Medical Genetics from the University of Cambridge in 2008, and their MBiochem in Biochemistry from the University of Oxford in 2004. Evangelia also holds an Intellectual Property Litigation Certificate.